SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand? is a research paper published in Advanced Drug Delivery Reviews (2021). On theSindex it has a DataRank of 0. It has been cited 100 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01AI139119
National Institutes of Health
Grant: U54CA260517
National Institute of Allergy and Infectious Diseases
Grant: U19AI111825
NIAID NIH HHS
Grant: R01 AI125567
National Institutes of Health
Grant: 5U19AI111825-02
Modulation of Human Dendritic Cell Development by Adjuvants and Vaccines
National Institutes of Health
Grant: 5R01AI139119-03
Regulation of the IgG Fc domain repertoire
National Institutes of Health
Grant: 3U54CA260517-02S2
Mechanisms and Duration of Immunity to SARS-CoV-2
Stanford University
Influential Citations
3
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of The representative COVID-19 cohort Munich (KoCo19): from the beginning of the pandemic to the Delta virus variant
Additional file 1 of The representative COVID-19 cohort Munich (KoCo19): from the beginning of the pandemic to the Delta virus variant
Additional file 2 of The representative COVID-19 cohort Munich (KoCo19): from the beginning of the pandemic to the Delta virus variant
Additional file 2 of The representative COVID-19 cohort Munich (KoCo19): from the beginning of the pandemic to the Delta virus variant
Additional file 3 of The representative COVID-19 cohort Munich (KoCo19): from the beginning of the pandemic to the Delta virus variant
Additional file 3 of The representative COVID-19 cohort Munich (KoCo19): from the beginning of the pandemic to the Delta virus variant
Additional file 4 of The representative COVID-19 cohort Munich (KoCo19): from the beginning of the pandemic to the Delta virus variant
Additional file 4 of The representative COVID-19 cohort Munich (KoCo19): from the beginning of the pandemic to the Delta virus variant